MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$14,576K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of marketab...
Deferred revenue
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Accounts receivable, net
Accrued expenses and other liabi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-07-31
Net loss
-23,487
49,390
-98,818
-60,096
Depreciation and amortization
355
102
615
252
Stock-based compensation expense
5,068
-817
6,853
5,379
Realized loss (gain) from sale of marketable securities
-11
-525
1,165
587
Non cash operating lease expense
-
605
-251
218
Non-cash operating lease expense
158
-
-
-
Accretion of discount on marketable securities
-100
-659
29
-7
Foreign currency exchange loss (gain)
-1,687
-6,324
7,364
-485
Non-cash interest expense and amortization of issuance costs
4,432
1,227
7,116
3,453
Fair value adjustment to derivative liability
-1,605
-2,120
-206
-1,100
Impairment of right of use assets
-
0
1,190
-
Research and development tax credit receivable
1,355
15,425
-9,790
-826
Accounts receivable, net
7,322
-3,186
3,853
1,926
Inventory
665
2,971
457
-
Prepaid expenses and other assets
184
-13,941
4,760
-1,597
Accounts payable
-149
-1,902
3,583
2,510
Accrued expenses
-
-
-
-8,199
Accrued expenses and other liabilities
-5,220
326
-4,154
-
Deferred revenue
10,711
-10,608
10,758
493
Net cash used in operating activities
-14,455
45,364
-72,483
-54,502
Purchases of marketable securities
16,428
-20,988
85,793
19,979
Sales and maturities of marketable securities
15,730
-22,525
86,212
41,677
Acquisition of property and equipment
121
-156
1,573
290
Disposal of property and equipment
-
-
12
-
Capitalized website development costs
82
-205
247
147
Net cash used in investing activities
-901
-1,188
-1,389
21,261
Proceeds from sale of convertible notes, net of offering costs
-
-389
139,438
-
Proceeds from the royalty agreement
-
-
-662
21,921
Proceeds from the royalty agreement, net of issuance costs
-
21,670
-
-
Issuance of common stock from equity incentive plans
793
-1,311
1,944
595
Issuance of common stock from employee stock purchase plan
672
-460
460
694
Net cash provided by financing activities
1,465
-1,749
141,180
23,210
Effect of exchange rate changes
-1,683
-5,873
1,319
2,723
Net decrease in cash, cash equivalents and restricted cash
-15,574
36,554
68,627
-7,308
Cash, cash equivalents and restricted cash at beginning of the period
230,145
244,297
182,978
-
Cash, cash equivalents and restricted cash at end of the period
214,571
230,145
244,297
-
Less restricted cash in other assets
803
803
-
-
Cash and cash equivalents
213,768
229,342
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Issuance of common stock
from equity...
$793K
Issuance of common stock
from employee stock...
$672K
Net cash provided by
financing activities
$1,465K
Net decrease in
cash, cash...
-$15,574K
Canceled cashflow
$1,465K
Deferred revenue
$10,711K
Stock-based compensation
expense
$5,068K
Non-cash interest
expense and...
$4,432K
Foreign currency
exchange loss (gain)
-$1,687K
Fair value
adjustment to derivative...
-$1,605K
Depreciation and
amortization
$355K
Non-cash operating lease
expense
$158K
Realized loss (gain) from
sale of marketable...
-$11K
Sales and maturities
of marketable...
$15,730K
Net cash used in
operating activities
-$14,455K
Effect of exchange rate
changes
-$1,683K
Canceled cashflow
$24,027K
Net cash used in
investing activities
-$901K
Canceled cashflow
$15,730K
Net loss
-$23,487K
Accounts receivable, net
$7,322K
Accrued expenses and
other liabilities
-$5,220K
Research and development
tax credit...
$1,355K
Inventory
$665K
Prepaid expenses and
other assets
$184K
Accounts payable
-$149K
Accretion of discount on
marketable securities
-$100K
Purchases of marketable
securities
$16,428K
Acquisition of property and
equipment
$121K
Capitalized website
development costs
$82K
Buy us a coffee
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)